NovaLipids’ core competency lies in the formulation of customized liposome-based delivery systems for new and existing animal health products. Liposomes are small particles, composed of phospholipids and other components that spontaneously form closed structures in aqueous environments. NovaLipids’ products can be designed to optimize the delivery of a wide variety of drugs and vaccines.

Customization of our delivery system involves consideration of several key factors including:

• Type of lipid
  
• Composition of the compound to be encapsulated
  
• Surface charge
  
• Size
  
• Encapsulation efficiency
  

The benefits of our delivery system include:

• Increased efficacy
  
• Improved pharmakokinectics
  
• Increased stability
  
• Reduced toxicity
  
• Increased immunogenicity